These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 22535617
1. Metastases to retroperitoneal or lateral pelvic lymph nodes indicated unfavorable survival and high pelvic recurrence rates in a cohort of 102 patients with low rectal adenocarcinoma. Quadros CA, Falcão MF, Carvalho ME, Ladeia PA, Lopes A. J Surg Oncol; 2012 Nov; 106(6):653-8. PubMed ID: 22535617 [Abstract] [Full Text] [Related]
2. Retroperitoneal and lateral pelvic lymphadenectomy mapped by lymphoscintigraphy and blue dye for rectal adenocarcinoma staging: preliminary results. Quadros CA, Lopes A, Araújo I, Fahel F, Bacellar MS, Dias CS. Ann Surg Oncol; 2006 Dec; 13(12):1617-21. PubMed ID: 17009148 [Abstract] [Full Text] [Related]
3. Retroperitoneal and lateral pelvic lymphadenectomy mapped by lymphoscintigraphy for rectal adenocarcinoma staging. Quadros CA, Lopes A, Araújo I. Jpn J Clin Oncol; 2010 Aug; 40(8):746-53. PubMed ID: 20457722 [Abstract] [Full Text] [Related]
4. Comparative outcome between chemoradiotherapy and lateral pelvic lymph node dissection following total mesorectal excision in rectal cancer. Kim JC, Takahashi K, Yu CS, Kim HC, Kim TW, Ryu MH, Kim JH, Mori T. Ann Surg; 2007 Nov; 246(5):754-62. PubMed ID: 17968166 [Abstract] [Full Text] [Related]
5. Indication and benefit of pelvic sidewall dissection for rectal cancer. Sugihara K, Kobayashi H, Kato T, Mori T, Mochizuki H, Kameoka S, Shirouzu K, Muto T. Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749 [Abstract] [Full Text] [Related]
9. Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection. Kobayashi H, Mochizuki H, Kato T, Mori T, Kameoka S, Shirouzu K, Sugihara K. Dis Colon Rectum; 2009 Apr; 52(4):567-76. PubMed ID: 19404054 [Abstract] [Full Text] [Related]
10. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision. Laurent C, Nobili S, Rullier A, Vendrely V, Saric J, Rullier E. J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330 [Abstract] [Full Text] [Related]
12. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Jeyarajah S, Sutton CD, Miller AS, Hemingway D, Leicester Colorectal Specialist Group. Colorectal Dis; 2007 Nov; 9(9):808-15. PubMed ID: 17441969 [Abstract] [Full Text] [Related]
13. [Total excision of the mesorectum in cancer of the lower and middle rectum. Oncological and functional results]. Kneist W, Heintz A, Wolf HK, Junginger T. Chirurg; 2003 Feb; 74(2):125-31. PubMed ID: 12599030 [Abstract] [Full Text] [Related]
14. Patterns of lateral pelvic lymph node metastases and micrometastases for patients with lower rectal cancer. Wang C, Zhou ZG, Yu YY, Li Y, Lei WZ, Cheng Z, Chen ZX. Eur J Surg Oncol; 2007 May; 33(4):463-7. PubMed ID: 17081722 [Abstract] [Full Text] [Related]
19. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Akiyoshi T, Watanabe T, Miyata S, Kotake K, Muto T, Sugihara K, Japanese Society for Cancer of the Colon and Rectum. Ann Surg; 2012 Jun; 255(6):1129-34. PubMed ID: 22549752 [Abstract] [Full Text] [Related]